News

Innovative left atrial appendage closure device offers proven alternative to anticoagulant drugs for patients in atrial fibrillation at high risk for stroke Boston Scientific Corporation's WATCHMAN® Left Atrial Appendage (LAA) Closure Device...

CorMatrix Cardiovascular, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the company full IDE approval for its ongoing multi-center, prospective, randomized clinical trial aiming to demonstrate the safety and...

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation and other cardiovascular diseases, announced results of analyses of atrial fibrillation and pharmacogenetic data from the BEST...

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that a study demonstrating a reduction in total mortality after cardiac revascularization in patients prescribed a LifeVest® Wearable...

HeartSine® Technologies, Inc., a world leader in personal and public access defibrillators, announced the launch of a new global website at www.heartsine.com. Founded in Belfast in 1997, HeartSine since has expanded across the globe and is...

Cardiac Science AEDs will be Deployed in Government Medical Clinics Cardiac Science Corporation, an Opto Circuits Group company and a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices,...

Abiomed Inc., a leading provider of breakthrough heart support technologies, announced Symphony™, a new synchronized minimally invasive implantable cardiac assist device, designed to treat chronic patients with moderate heart failure by...

Biosign Technologies Inc., a company focused on non-invasive monitoring of common health risks associated with blood pressure, lifestyle and medication, is pleased to announce they have developed proprietary algorithms that can be utilized on...

Solution uses evidence-based guidelines to reduce complications from inappropriate surgeries MedSolutions, a leading provider of quality-driven medical cost management services, announced the launch of its Implantable Cardioverter...

Perminova, developer of web-based software for use in the nation’s leading cardiology centers, announced that it has secured $7 million in venture capital. The company will use the funds to fuel growth as it pioneers the development and...